What is he best known for?
The fields of study he is best known for:
- Gene
- Genetics
- Immune system
His scientific interests lie mostly in Cell biology, Genetics, Innate immune system, Gene and Gene expression.
His Cell biology research incorporates themes from BAG3 and Necroptosis.
As part of his studies on Genetics, he often connects relevant subjects like Immunology.
His Innate immune system research is multidisciplinary, relying on both Secondary infection, Protein kinase B, Anaerobic glycolysis and Immunity.
His biological study spans a wide range of topics, including Crohn's disease, IRGM and ATG16L1.
His Gene expression research includes elements of RNA, Transcription factor, Blood cell, Monocyte and Epigenetics.
His most cited work include:
- Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 (1839 citations)
- Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. (1061 citations)
- mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity (827 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Cell biology, Genetics, Immunology, Immune system and Gene.
Aylwin Ng has researched Cell biology in several fields, including Innate immune system, Ubiquitin, BAG3 and Mitophagy.
His Innate immune system research is multidisciplinary, incorporating elements of Secondary infection, Transcription factor, Ubiquitin ligase and Anaerobic glycolysis.
His Genetics research incorporates elements of Disease and ATG16L1.
His Immunology study incorporates themes from Receptor and Candida albicans.
The various areas that he examines in his Gene study include Virus and Virology.
He most often published in these fields:
- Cell biology (44.71%)
- Genetics (42.35%)
- Immunology (35.29%)
What were the highlights of his more recent work (between 2015-2021)?
- Immune system (28.24%)
- Cell biology (44.71%)
- Computational biology (21.18%)
In recent papers he was focusing on the following fields of study:
Aylwin Ng mostly deals with Immune system, Cell biology, Computational biology, Immunology and Genetics.
His Immune system research is multidisciplinary, incorporating perspectives in ATG16L1, Genetic association and Genotype.
His research in Cell biology intersects with topics in Innate immune system, Ubiquitin ligase and Cytokine.
The concepts of his Computational biology study are interwoven with issues in Regulator, CRISPR and Functional genomics.
His research integrates issues of Cancer research, IRF1 and Inflammatory bowel disease in his study of Immunology.
His study in the field of Gene, Genetic variation, Kinase and Phosphorylation is also linked to topics like Translational regulation.
Between 2015 and 2021, his most popular works were:
- Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease (214 citations)
- Functional CRISPR screening identifies the ufmylation pathway as a regulator of SQSTM1/p62 (87 citations)
- Understanding human immune function using the resources from the Human Functional Genomics Project (42 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Genetics
- Immune system
Aylwin Ng focuses on Immune system, Computational biology, Functional genomics, Systems biology and IRF1.
His Immune system study combines topics in areas such as Inflammation, Antigen and Virulence.
Aylwin Ng interconnects Regulator, RNA interference, Genome editing, Unfolded protein response and Regulation of gene expression in the investigation of issues within Computational biology.
Aylwin Ng has included themes like Immunology, Effector, Immunity, Disease and Regulatory T cell in his IRF1 study.
His Immunity study combines topics from a wide range of disciplines, such as Virus, Interferon, Virology and Pathogen.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
